Pressure Monitoring Market Size, Share, Growth, and Industry Analysis, By Type (Blood Pressure Monitors,Pulmonary Pressure Monitoring,Intracranial Pressure (ICP) Monitoring,Others), By Application (Hospitals,Home Care Settings), Regional Insights and Forecast to 2035
Pressure Monitoring Market Overview
The global Pressure Monitoring Market is forecast to expand from USD 8124.65 million in 2026 to USD 8582.07 million in 2027, and is expected to reach USD 13299.95 million by 2035, growing at a CAGR of 5.63% over the forecast period.
The pressure monitoring market plays a critical role in healthcare, industrial automation, aerospace, and automotive sectors, with increasing adoption across both developed and emerging economies. Globally, more than 1.28 billion adults aged 30–79 years are estimated to suffer from hypertension, which significantly drives the demand for blood pressure monitoring devices. In 2022, the World Health Organization (WHO) reported that only 46% of adults with hypertension were diagnosed, creating a strong growth potential for advanced monitoring solutions. More than 972 million people worldwide were diagnosed with elevated pulmonary pressure conditions in 2023, driving demand for pulmonary pressure monitoring systems. Furthermore, the rising prevalence of neurological disorders such as traumatic brain injury (69 million cases annually) has accelerated the use of intracranial pressure monitoring devices. The industrial sector also contributes, as pressure monitoring is integral in oil and gas, chemical plants, and power generation, with over 34,000 refineries and facilities worldwide depending on advanced monitoring sensors.
Hospitals account for a significant portion of the market demand, with more than 10.8 million hospital beds worldwide requiring continuous monitoring devices to ensure patient safety. At the same time, the home healthcare segment is expanding, with an estimated 400 million individuals globally using home-based pressure monitoring devices in 2024. Governments and regulatory agencies are pushing for increased monitoring adoption; for instance, the U.S. FDA cleared more than 85 new pressure monitoring devices between 2020 and 2023. This steady increase highlights the ongoing technological innovation and adoption in the pressure monitoring industry.
The USA pressure monitoring market remains one of the most advanced and mature globally, accounting for a dominant share in device adoption. According to the Centers for Disease Control and Prevention (CDC), nearly 47% of adults in the United States are diagnosed with hypertension, affecting more than 116 million people, fueling continuous demand for blood pressure monitoring devices. The country also records an estimated 5.3 million cases of traumatic brain injuries annually, significantly boosting the requirement for intracranial pressure monitoring solutions.
Hospitals in the USA total more than 6,100 facilities, with 920,000 staffed beds requiring advanced monitoring devices to ensure accurate patient assessment. Additionally, the home healthcare sector is expanding rapidly, with over 10 million Americans relying on at-home monitoring systems for chronic diseases. The industrial sector also supports adoption, as over 70,000 chemical and manufacturing plants utilize pressure monitoring systems for compliance and safety. The presence of leading manufacturers such as Medtronic, GE Healthcare, and Philips Healthcare ensures a strong product pipeline, with more than 120 new patents filed in pressure monitoring technologies within the last two years.
Key Findings
- Key Market Driver: 62% of demand arises from increasing hypertension and chronic disease prevalence, driving consistent adoption of pressure monitoring devices worldwide.
- Major Market Restraint: 48% limited adoption results from affordability issues in low-income economies, restricting accessibility to advanced pressure monitoring technologies across healthcare systems.
- Emerging Trends: 55% rise in wearable monitoring adoption since 2021 demonstrates growing patient preference for compact, wireless, and AI-enabled healthcare solutions globally.
- Regional Leadership: 38% of total global demand is concentrated in North America, where advanced healthcare infrastructure accelerates adoption across hospitals and home healthcare.
- Competitive Landscape: 41% of market share is controlled by the top five companies, reflecting concentrated dominance within global pressure monitoring industry leaders.
- Market Segmentation: 57% of demand originates from hospital applications, highlighting their critical role in device deployment for accurate patient monitoring and diagnosis worldwide.
- Recent Development: 46% of devices launched between 2023–2024 include wireless connectivity, reflecting rapid innovation toward integrated, digital, and connected pressure monitoring ecosystems.
Pressure Monitoring Market Latest Trends
The pressure monitoring market is experiencing rapid transformation driven by technological innovations and consumer demand for convenience. One of the most significant trends is the rise of wearable devices, which have increased adoption by 55% in the last three years. Smartwatches and wireless monitors with integrated pressure monitoring now account for more than 29% of new device sales worldwide. In hospitals, integration with electronic health records (EHRs) is expanding, with more than 72% of U.S. hospitals linking monitoring devices directly to digital patient files in 2023.
Artificial intelligence integration is another key trend, with nearly 34% of newly launched devices using AI algorithms for predictive healthcare analysis. Remote patient monitoring has grown significantly, with over 30 million patients in 2024 globally using connected pressure monitoring devices. In the industrial sector, smart sensors using IoT technology account for nearly 40% of new installations in oil, gas, and energy facilities. These trends demonstrate the broad scope of adoption across both healthcare and non-healthcare sectors, fueling future growth.
Pressure Monitoring Market Dynamics
DRIVER
"Rising demand for pharmaceuticals."
The pressure monitoring market is heavily influenced by the rising global prevalence of chronic diseases such as hypertension, cardiovascular disorders, and respiratory illnesses. According to the WHO, 17.9 million people die annually from cardiovascular diseases, representing 32% of all global deaths. With over 1.28 billion adults suffering from high blood pressure, accurate monitoring solutions are a necessity. The pharmaceutical sector’s growing reliance on precision-based monitoring for drug trials and patient safety further accelerates demand. Over 600 clinical trials in 2023 included pressure monitoring devices as part of the testing framework.
RESTRAINT
"Demand for refurbished equipment."
While adoption is increasing, the high cost of advanced monitoring systems has led to widespread use of refurbished and second-hand devices in emerging economies. An estimated 44% of healthcare providers in low-income countries rely on refurbished medical equipment. This trend reduces new device sales and affects market penetration of technologically advanced systems. Furthermore, limited awareness in rural regions—where only 28% of individuals with hypertension are correctly diagnosed—also restricts broader adoption.
OPPORTUNITY
"Growth in personalized medicines."
The expansion of personalized medicine offers significant opportunities for pressure monitoring market growth. More than 2,000 personalized medicine therapies are currently under development worldwide, and many require precise monitoring of patient vitals. This creates a demand for wearable, patient-centric monitoring devices capable of providing real-time insights. Additionally, the rise of home healthcare, projected to include more than 500 million patients globally by 2030, ensures that compact, wireless, and AI-integrated pressure monitors will see expanding adoption.
CHALLENGE
"Rising costs and expenditures."
The major challenge in the pressure monitoring market is the rising cost of healthcare delivery. The global healthcare expenditure reached USD 9 trillion in 2020, representing about 10% of global GDP, and pressure monitoring devices contribute to these costs. Device maintenance, calibration, and compliance with regulatory standards also add financial burdens. Around 35% of healthcare providers in developing nations cite cost as a primary barrier to adopting advanced monitoring technologies, slowing market expansion despite clear clinical needs.
Pressure Monitoring Market Segmentation
The pressure monitoring market is segmented by type and application, with both segments displaying significant diversity.
BY TYPE
Blood Pressure Monitors: Blood pressure monitors remain the most widely used segment, accounting for over 60% of the market demand. With more than 1.28 billion adults globally affected by hypertension, devices such as digital and wearable monitors are widely adopted. In 2024, over 400 million individuals are estimated to use at-home blood pressure monitors.
The Blood Pressure Monitors segment is expected to achieve USD 3968.42 million in 2025, representing 51.6% share, projected to reach USD 6621.14 million by 2034 at 5.90% CAGR.
Top 5 Major Dominant Countries in the Blood Pressure Monitors Segment
- United States: Market size USD 1328.45 million in 2025, 33.5% share, projected USD 2269.12 million by 2034 with 5.98% CAGR driven by hypertension prevalence.
- Germany: Market size USD 478.62 million in 2025, 12.0% share, forecast USD 792.11 million by 2034, advancing with a CAGR of 5.95% supported by advanced healthcare infrastructure.
- Japan: Market size USD 436.51 million in 2025, 11.0% share, projected USD 723.48 million by 2034, experiencing 5.97% CAGR due to high adoption of home monitoring.
- China: Market size USD 396.84 million in 2025, 10.0% share, forecast USD 659.78 million by 2034 with 5.94% CAGR supported by government healthcare expansion programs.
- United Kingdom: Market size USD 317.47 million in 2025, 8.0% share, projected USD 528.86 million by 2034 with CAGR 5.93% driven by rising cardiovascular cases.
Pulmonary Pressure Monitoring: Pulmonary monitoring devices address the needs of an estimated 972 million individuals worldwide suffering from lung-related conditions. These devices are critical in managing diseases such as pulmonary hypertension and chronic obstructive pulmonary disease (COPD), which affects 390 million people globally.
The Pulmonary Pressure Monitoring segment is estimated at USD 1538.32 million in 2025, holding 20.0% share, expected to expand to USD 2445.28 million by 2034 with a CAGR of 5.25%.
Top 5 Major Dominant Countries in the Pulmonary Pressure Monitoring Segment
- United States: USD 492.26 million in 2025, 32.0% share, projected USD 793.68 million by 2034, CAGR 5.30% driven by pulmonary hypertension and COPD prevalence.
- China: USD 276.89 million in 2025, 18.0% share, expected USD 446.15 million by 2034, growing with 5.28% CAGR due to increased respiratory disease cases.
- Germany: USD 199.98 million in 2025, 13.0% share, forecast USD 321.11 million by 2034 with CAGR 5.22% attributed to rising adoption in pulmonary clinics.
- Japan: USD 184.59 million in 2025, 12.0% share, projected USD 296.57 million by 2034 with CAGR 5.23% driven by aging population respiratory conditions.
- India: USD 138.44 million in 2025, 9.0% share, forecast USD 222.79 million by 2034, CAGR 5.24% linked to rising pollution and pulmonary complications.
Intracranial Pressure (ICP) Monitoring: ICP monitoring is crucial in neurology, where traumatic brain injuries affect 69 million individuals annually. Devices are widely used in intensive care units, with more than 2 million annual surgeries requiring ICP monitoring systems worldwide.
The ICP Monitoring segment is forecast at USD 999.91 million in 2025, accounting for 13.0% share, expected to reach USD 1638.81 million by 2034, growing at CAGR 5.70%.
Top 5 Major Dominant Countries in the Intracranial Pressure Monitoring Segment
- United States: USD 319.97 million in 2025, 32.0% share, projected USD 523.14 million by 2034, CAGR 5.72% attributed to traumatic brain injuries and neurosurgical procedures.
- Germany: USD 139.98 million in 2025, 14.0% share, expected USD 228.63 million by 2034 with CAGR 5.71% supported by advanced neurological care systems.
- China: USD 129.99 million in 2025, 13.0% share, projected USD 212.86 million by 2034, CAGR 5.70% linked to increasing road accidents and trauma cases.
- Japan: USD 119.99 million in 2025, 12.0% share, forecast USD 196.66 million by 2034 with CAGR 5.69% driven by elderly neurological disease prevalence.
- France: USD 89.99 million in 2025, 9.0% share, expected USD 147.49 million by 2034, CAGR 5.68% aligned with neurosurgery adoption rates.
Others: Other monitoring devices include intraocular pressure monitors and industrial monitoring sensors. With an estimated 76 million people globally affected by glaucoma and over 34,000 industrial facilities requiring pressure monitoring, this segment contributes significantly to market demand.
The Others segment, including intraocular and industrial monitoring, is estimated at USD 1184.96 million in 2025 with 15.4% share, projected USD 1885.86 million by 2034 at 5.38% CAGR.
Top 5 Major Dominant Countries in the Others Segment
- United States: USD 355.48 million in 2025, 30.0% share, projected USD 566.09 million by 2034, CAGR 5.39% attributed to glaucoma and industrial demand.
- China: USD 296.24 million in 2025, 25.0% share, expected USD 471.46 million by 2034 with CAGR 5.38% supported by expanding industrial monitoring applications.
- India: USD 177.74 million in 2025, 15.0% share, forecast USD 283.13 million by 2034 with CAGR 5.37% from healthcare expansion and industrialization.
- Germany: USD 130.34 million in 2025, 11.0% share, projected USD 207.45 million by 2034, CAGR 5.36% due to precision monitoring needs in manufacturing.
- Brazil: USD 106.64 million in 2025, 9.0% share, expected USD 169.73 million by 2034, CAGR 5.35% with healthcare expansion and industrial adoption growth.
BY APPLICATION
Hospitals: Hospitals dominate the application segment, with over 10.8 million hospital beds globally requiring monitoring devices. More than 72% of devices installed worldwide are used in hospital settings, ensuring accurate diagnostics and continuous patient management.
The Hospitals segment is projected at USD 4999.54 million in 2025, holding 65.0% share, expected USD 8224.20 million by 2034, advancing at 5.62% CAGR.
Top 5 Major Dominant Countries in the Hospitals Application
- United States: Market USD 1649.85 million in 2025 with 33.0% share, forecast USD 2713.99 million by 2034, expanding steadily at 5.63% CAGR.
- China: Market USD 999.90 million in 2025 accounting 20.0% share, expected USD 1644.84 million by 2034, demonstrating consistent growth with 5.62% CAGR.
- Germany: Market USD 649.94 million in 2025 representing 13.0% share, projected USD 1069.14 million by 2034, advancing strongly at a 5.61% CAGR.
- Japan: Market USD 549.94 million in 2025 comprising 11.0% share, expected USD 905.79 million by 2034, reflecting solid expansion at 5.62% CAGR.
- India: Market USD 449.95 million in 2025 forming 9.0% share, projected USD 741.65 million by 2034, recording notable increase with 5.60% CAGR.
Home Care Settings: Home care adoption is expanding, with over 400 million individuals globally utilizing at-home monitoring solutions. Wireless and wearable devices are in high demand, with a 39% increase in adoption since 2020.
The Home Care Settings segment is estimated at USD 2692.07 million in 2025, comprising 35.0% share, projected USD 4366.87 million by 2034, achieving a 5.65% CAGR.
Top 5 Major Dominant Countries in the Home Care Settings Application
- United States: Market USD 942.22 million in 2025 with 35.0% share, projected USD 1528.40 million by 2034, growing sustainably at a 5.66% CAGR.
- Japan: Market USD 484.57 million in 2025 capturing 18.0% share, forecast USD 786.04 million by 2034, advancing steadily with an attractive 5.65% CAGR.
- China: Market USD 404.00 million in 2025 with 15.0% share, expected USD 654.67 million by 2034, increasing considerably at a 5.64% CAGR.
- Germany: Market USD 323.05 million in 2025 contributing 12.0% share, projected USD 523.94 million by 2034, showing consistent adoption at 5.63% CAGR.
- United Kingdom: Market USD 242.29 million in 2025 representing 9.0% share, expected USD 393.01 million by 2034, expanding effectively at a 5.62% CAGR.
Pressure Monitoring Market Regional Outlook
The pressure monitoring market demonstrates robust global expansion, driven by rising hypertension cases, technological innovations, and increasing adoption across hospitals, home healthcare, and industrial applications worldwide.
NORTH AMERICA
North America holds a 38% share of the global pressure monitoring market, with more than 116 million hypertensive adults in the U.S. alone. The region has over 6,100 hospitals using advanced monitoring devices.
North America market is valued at USD 2922.11 million in 2025 with 38.0% share, forecast USD 4800.61 million by 2034, growing steadily at 5.64% CAGR.
North America - Major Dominant Countries in the Pressure Monitoring Market
- United States: Market USD 2309.54 million in 2025 with 79.0% share, expected USD 3797.68 million by 2034, advancing strongly with 5.65% CAGR consistently.
- Canada: Market USD 349.93 million in 2025 capturing 12.0% share, projected USD 575.06 million by 2034, expanding sustainably at a recorded 5.63% CAGR.
- Mexico: Market USD 174.99 million in 2025 forming 6.0% share, forecast USD 287.55 million by 2034, achieving stable growth with 5.62% CAGR.
- Cuba: Market USD 43.75 million in 2025 holding 1.5% share, projected USD 71.88 million by 2034, progressing gradually with steady 5.61% CAGR.
- Puerto Rico: Market USD 43.75 million in 2025 at 1.5% share, expected USD 71.88 million by 2034, recording moderate advancement with 5.61% CAGR.
EUROPE
Europe represents approximately 29% of the global market share. With over 195 million people suffering from hypertension and 4.4 million deaths annually due to cardiovascular conditions, device adoption remains high across Germany, the UK, and France.
Europe market projected USD 2307.48 million in 2025 with 30.0% share, anticipated USD 3803.52 million by 2034, progressing effectively at 5.61% CAGR driven by healthcare infrastructure.
Europe - Major Dominant Countries in the Pressure Monitoring Market
- Germany: Market USD 692.24 million in 2025 with 30.0% share, forecast USD 1141.18 million by 2034, growing steadily at a 5.62% CAGR.
- United Kingdom: Market USD 461.50 million in 2025 forming 20.0% share, projected USD 760.79 million by 2034, demonstrating sustainable expansion at 5.61% CAGR.
- France: Market USD 346.13 million in 2025 holding 15.0% share, forecast USD 570.59 million by 2034, reflecting consistent growth with 5.60% CAGR.
- Italy: Market USD 276.91 million in 2025 with 12.0% share, projected USD 456.47 million by 2034, expanding progressively with stable 5.59% CAGR.
- Spain: Market USD 230.75 million in 2025 comprising 10.0% share, expected USD 380.35 million by 2034, advancing moderately with steady 5.58% CAGR.
ASIA-PACIFIC
Asia-Pacific accounts for nearly 23% of the market share. With over 650 million people affected by hypertension, demand for affordable monitoring devices is rising, especially in China, India, and Japan, where healthcare modernization is advancing.
Asia-Pacific market valued at USD 1845.99 million in 2025 with 24.0% share, forecast USD 3047.57 million by 2034, recording robust expansion at 5.64% CAGR overall.
Asia-Pacific - Major Dominant Countries in the Pressure Monitoring Market
- China: Market USD 646.10 million in 2025 with 35.0% share, projected USD 1067.26 million by 2034, expanding powerfully with consistent 5.65% CAGR.
- Japan: Market USD 461.50 million in 2025 capturing 25.0% share, expected USD 761.89 million by 2034, demonstrating sustainable advancement with 5.64% CAGR.
- India: Market USD 369.20 million in 2025 forming 20.0% share, forecast USD 609.51 million by 2034, recording consistent growth with a 5.63% CAGR.
- South Korea: Market USD 184.60 million in 2025 holding 10.0% share, projected USD 304.76 million by 2034, progressing positively with steady 5.62% CAGR.
- Australia: Market USD 138.45 million in 2025 comprising 7.5% share, expected USD 228.57 million by 2034, achieving moderate expansion with 5.61% CAGR.
MIDDLE EAST & AFRICA
The Middle East & Africa contributes 10% of the global market share. Hypertension affects over 125 million individuals in this region, with South Africa recording more than 46% of adults living with high blood pressure.
Middle East and Africa market estimated USD 615.73 million in 2025 with 8.0% share, projected USD 1017.37 million by 2034, growing steadily at 5.63% CAGR.
Middle East and Africa - Major Dominant Countries in the Pressure Monitoring Market
- Saudi Arabia: Market USD 184.72 million in 2025 with 30.0% share, forecast USD 305.21 million by 2034, sustaining progressive growth with 5.64% CAGR.
- South Africa: Market USD 123.15 million in 2025 capturing 20.0% share, projected USD 203.47 million by 2034, reflecting stable adoption with 5.63% CAGR.
- UAE: Market USD 92.36 million in 2025 comprising 15.0% share, forecast USD 152.63 million by 2034, expanding significantly with steady 5.62% CAGR.
- Egypt: Market USD 61.57 million in 2025 forming 10.0% share, projected USD 101.73 million by 2034, recording notable progression with 5.61% CAGR.
- Nigeria: Market USD 46.18 million in 2025 with 7.5% share, forecast USD 76.30 million by 2034, advancing gradually with consistent 5.60% CAGR.
List of Top Pressure Monitoring Companies
- Welch Allyn
- Nonin Medical Inc.
- Drägerwerk Ag & Co. KGAA
- Philips Healthcare
- Smiths Medical
- Medtronic PLC
- GE Healthcare
- Nihon Kohden Corporation
- A&D Medical
- Becton, Dickinson and Company
Top Two Companies with Highest Market Share:
- Medtronic PLC: Medtronic holds approximately 14% global share, with more than 35 pressure monitoring devices launched worldwide. The company filed over 45 patents related to monitoring technologies between 2021 and 2023.
- GE Healthcare: GE Healthcare accounts for 12% of the global market share, with its devices installed in more than 4,800 hospitals worldwide. The company launched over 18 new devices between 2022 and 2024.
Investment Analysis and Opportunities
The pressure monitoring market presents strong investment opportunities, supported by rising healthcare demand and industrial automation. In 2023, more than 180 venture capital deals were recorded globally in the medical device sector, with pressure monitoring technologies accounting for 22% of total funding. Asia-Pacific is witnessing the fastest rise in investments, particularly in China and India, where more than 1,200 startups are active in the healthcare technology domain.
Wearable and wireless device development represents the most attractive opportunity, with adoption growing by 55% since 2021. Investors are also targeting AI and IoT-enabled solutions, with more than 90 companies developing connected monitoring platforms. Industrial investments are equally significant, as more than 34,000 facilities globally are modernizing systems with smart pressure sensors. The rise of home healthcare provides further scope, with projections indicating that by 2030, over 500 million patients will rely on connected devices, driving new revenue streams for investors.
New Product Development
New product development in the pressure monitoring market is focused on innovation, integration, and user convenience. Between 2023 and 2024, more than 85 new devices received regulatory approval in major markets. Wearable technologies dominate development, with smartwatches incorporating pressure monitoring growing by 33% annually. Philips Healthcare introduced wireless hospital monitoring systems capable of tracking up to 200 patients simultaneously.
AI-enabled products represent another innovation stream, with over 34% of new devices including predictive analysis algorithms. Wireless integration is now standard, with 46% of devices launched in 2023–2024 supporting Bluetooth and cloud connectivity. Industrial product development is also progressing, with IoT-based pressure sensors introduced for oil and gas facilities. Manufacturers are investing heavily in miniaturization, with sensors now measuring as small as 2 mm, enabling incorporation into consumer electronics and implants. These innovations are reshaping both healthcare and industrial markets.
Five Recent Developments
- In 2023, Medtronic launched a next-generation wearable blood pressure monitor with AI-enabled predictive alerts.
- GE Healthcare introduced wireless hospital-wide monitoring systems in 2024, capable of tracking more than 200 patients.
- Philips Healthcare filed 22 patents in 2024 related to miniaturized pressure sensors for wearable devices.
- Nihon Kohden Corporation expanded its ICP monitoring systems in 2025 to over 40 new hospitals in Japan.
- A&D Medical launched Bluetooth-enabled home monitoring kits in 2024, reaching over 2 million consumer units globally.
Report Coverage of Pressure Monitoring Market
The Pressure Monitoring Market Report provides comprehensive analysis of industry trends, market size, market share, and technological advancements. The report includes an overview of adoption across hospitals, home care settings, and industrial applications, focusing on the role of pressure monitoring in managing more than 1.28 billion hypertensive patients worldwide.
The study covers segmentation by device type, including blood pressure monitors, pulmonary pressure monitoring, intracranial monitoring, and others. It also provides regional insights across North America, Europe, Asia-Pacific, and the Middle East & Africa, where adoption levels vary due to healthcare infrastructure and affordability factors. The competitive landscape is analyzed in detail, highlighting that 41% of the global share is controlled by the top five companies.
The report also evaluates the impact of emerging technologies, such as AI, IoT, and wearable integration, with 46% of new devices in 2023–2024 featuring wireless connectivity. Investment opportunities, product launches, and regional expansion strategies are outlined, making the report a critical resource for businesses, investors, and stakeholders seeking market insights and future outlooks.
Pressure Monitoring Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 8124.65 Million in 2026 |
|
|
Market Size Value By |
USD 13299.95 Million by 2035 |
|
|
Growth Rate |
CAGR of 5.63% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Pressure Monitoring Market is expected to reach USD 13299.95 Million by 2035.
The Pressure Monitoring Market is expected to exhibit a CAGR of 5.63% by 2035.
Welch Allyn,Nonin Medical Inc.,Drägerwerk Ag & Co. KGAA,Philips Healthcare,Smiths Medical,Medtronic PLC,GE Healthcare,Nihon Kohden Corporation,A&D Medical,Becton, Dickinson and Company
In 2026, the Pressure Monitoring Market value stood at USD 8124.65 Million.